STATEHOUSE – State Representative Steve Davisson (R-Salem) co-authored legislation that would allow terminally ill patients to try a drug or treatment that has gone through the first stage of approval for use. House Enrolled Act (HEA) 1065 was signed into law by Governor Pence.
“I am honored to have been a part of this life-changing legislation,” said Rep. Davisson. “This measure has the potential to save lives and allows for more opportunities for potential cures of terminal illnesses.”
HEA 1065 would allow patients under certain conditions to try experimental drugs, biological products or devices if they do not have a comparable or satisfactory treatment option. Under this bill, patients would qualify for experimental treatments if they are diagnosed with a terminal illness and the treatment option does not have a probable risk that is greater than the condition. However, a patient would still need to receive physician approval first.
“Under this law, Hoosiers will have broader access to experimental treatment,” said Rep. Davisson. “I look forward to seeing the positive impacts this will have on Hoosiers.”
For more information on HEA 1065, please visit iga.in.gov.